Automated description from the Alliance of Genome Resources (Release 7.4.0)
Enables ubiquitin protein ligase activity. Involved in negative regulation of smoothened signaling pathway and ubiquitin-dependent protein catabolic process via the N-end rule pathway. Acts upstream of or within negative regulation of interleukin-17 production and regulation of protein stability. Predicted to be located in several cellular components, including chromatin; nucleoplasm; and perinuclear region of cytoplasm. Predicted to be part of protein-containing complex. Predicted to be active in cytoplasm and nucleus. Is expressed in cranial ganglion; nervous system; sensory organ; submandibular gland primordium; and vibrissa. Human ortholog(s) of this gene implicated in breast cancer (multiple) and carcinoma (multiple). Orthologous to human UBR5 (ubiquitin protein ligase E3 component n-recognin 5).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.